SecBot SecBot
SECBOTREPLAY Home › Report › ONC

ONC · Chairman and CEO John Oyler filed a Form 144 on August 10, 2026,…

BeOne Medicines Ltd. · 144 filed Aug 10, 2026 at 16:36 ET

At the news

BEARISHIMPACT 6/10

144 filed Aug 10, 2026 at 16:36 ET

Chairman and CEO John Oyler filed a Form 144 on August 10, 2026, signaling intent to sell approximately $83.9 million worth of BeOne Medicines (ONC) ADS shares. The filing covers shares acquired via vested stock options and founder shares, and is part of a pre-arranged 10b5-1 trading plan that has already generated over $220 million in sales since mid-July 2026. While the 10b5-1 plan provides some cover, the sheer scale of selling by the CEO is a notable signal.

  • CEO John Oyler filed Form 144 to sell ADS shares valued at approximately $83.9 million.
  • The filing covers 229,115 shares acquired from vested stock options (March 2025) and 11,695 founder shares (October 2014).
  • Oyler has already sold ~$220 million in ONC ADS shares since July 10, 2026 under a 10b5-1 plan.
  • Recent 10b5-1 sales include: $52.99M (Jul 16), $40.89M (Jul 14), $36.36M (Jul 15), $20.16M (Jul 17).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access